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décrit un modèle expérimental de bronchoconstriction précoce induite par 
solisation d'un extrait d'Ascaris suum chez des moutons anesthésiés par de l'isoflurane et 
ix moutons adultes ont été anesthésiés et ventilés mécaniquement puis ont été exposés à un 
stimulus bronchoconstrictif sous forme d'un aérosol d'extrait d'Ascaris suum durant 25 
minutes. Tous les moutons ont été exposés deux fois à huit semaines d'intervalle à ce même 
stimulus. Les échanges gazeux ainsi que les paramètres respiratoires ont été mesurés 
régulièrement durant la période d'aérosolisation ainsi que durant les 60 minutes suivantes. 
A la fin de la période d'aérosolisation, une augmentation significative (p<0.05) des pressions 
de crête ( + 114%) et de plateau ( + 148% ), de la résistance expiratoire ( +93 % ) et de la pression 
partielle artérielle de gaz carbonique PaC02 (+25%) a été constatée, de même qu'une 
diminution significative (p<0.05) de la compliance respiratoire (-41 % ) et de la pression 
partielle artérielle d'oxygène Pa02 (-49%). Ces modifications sont restées stables durant toute 
la période d'observation. 
Ce modèle expérimental animal de bronchoconstriction offre de nombreux avantages : la 
stabilité hémodynamique et le confort de l'animal sont améliorés et la réaction de stress est 
inhibée. Il permet de plus une distribution optimale de l'antigène respiratoire et finalement 
évite l'utilisation d'un pléthysmographe corporel. 
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M>strac_! 
This study describes a simplified experimental model of early bronchoconstriction induced by 
aerosolization of Ascaris suum extract in isoflurane-anesthetized and mechanically ventilated 
sheep. 
Ten adult sheep were anesthetized, mechanically ventilated and then challenged with an 
aerosol of Ascaris suum extract during 25 minutes. All of them were challenged twice at eight 
weeks intervals. During the bronchoconstrictive challenges and the following sixty minutes, 
gas exchange was measured and respiratory mechanics parameters computed from a lung 
mechanics calculator. 
At the end of the challenge, a significant increase (p<0.05) was observed in peak (+ 114%) 
and plateau(+ 148%) pressures, expiratory resistance (+93%) and PaC02 (+25%) along with 
a significant decrease (p<0.05) in respiratory compliance (-41 %) and Pa02 (-49%). These 
changes remained stable throughout the 60 minutes study period. 
This model offers several advantages : hemodynamic stability and animal welfare are 
improved and the stress response is blunted. It allows an optimal distribution of the antigen 
and finally avoids the need of a body plethysmograph. 
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!: Introduction 
Due to a continuous increase in prevalence and morbidity, asthma will require considerable 
investigative effort in the future to better define its pathophysiology and to test new treatment 
modalities 1• Only limited studies can be done in asthmatic humans for safety reasons. 
Apprapriate animal models are therefore necessary to test hypotheses of underlying 
mechanism, to determine the significance of immunologie, pharmacologie, and cellular 
factors in human asthma. 
During the last fifty years, induced allergie branchoconstriction in animais has been 
extensively studied in three species1-4, namely the Guinea pig5, the Basenji-Greyhound dog6 
and the Rhesus monkey7. More recently, murine models have been developed to investigate 
the molecular and immunological mechanisms of branchial asthma8'9 • 
The pathophysiological features of the sheep asthma model are also well characterized10-16 . 
Sheep frequently have a natural cutaneous sensitivity to Ascaris suum antigen, presumably 
resulting from exposure on the fann to pigs in whom raundworm infestation is endemic. 
Further active sensitization of the sheep can be achieved by repeated inhalational challenge 
with Ascaris suum antigen. Sensitized animais respond to this airway challenge with induced 
branchoconstriction characterized by changes in respiratory mechanics, lung volumes and gas 
exchange. An increase in airflow resistance and a fall in dynamic lung compliance are 
observed, associated with pulmonary hyperinflation and a decrease in arterial oxygen tension, 
while carbon dioxide tension usually remains unchanged1-4. As seen in human asthma, 
allergie sheep often exhibit a dual respiratory response to inhaled Ascaris suum antigen : an 
immediate branchoconstriction (early phase) followed 6 to 8 hours later in 30-50% of cases 
by a second more severe branchial obstruction involving inflammatory mechanisms (late 
phase). Sheep have usually been studied in .the conscious state by means of the body 
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plethysmograph technique10-16. Long et al. already described a mechanically ventilated and 
anesthetized sheep model of asthma which was however mainly used to study pulmonary and 
systemic hemodynamics 16 . In order to improve animal welfare and to assess more precisely 
the modifications of respiratory mechanics and gaz exchange, we designed an experimental 
model of early bronchoconstriction using isoflurane-anesthetized and mechanically ventilated 
sheep sensitized with Ascaris suum antigen. 
2. Animais and methods 
The study protocol was approved by the Local Committee on Animal Research and has been 
performed according to the Helsinki convention for the use and care of animals. Ten adult 
sheeps with a mean weight of 44 ± 9 kg (mean ± SD) were included in this study. All ofthem 
were challenged twice at eight weeks intervals. 
After intramuscular premedication with xylazin (0.15 mg/kg), the sheep were anesthetized 
with intravenous thiopentone (10 mg/kg), their trachea intubated and connected to the 
ventilator in prone position. A continuous positive pressure ventilation with a tidal volume of 
12-14 ml/kg, a PEEP of 5 cmH20, an I:E ratio of 1 :2 and an inspiratory pause of 10% of the 
respiratory cycle was used. Respiratory frequency was set to preserve normocarbia (PaC02 4-
5 kPa). Anesthesia was maintained with an inspired concentration of isoflurane 1 % in a 
mixture of oxygen and air (Fi02 50%). To avoid distension of the rumen, a large-bore 
orogastric tube was inserted. Animals were perfused with 100-200 ml/h of ringer lactate 
solution and a peripheral arterial cannula was inserted. Electrocardiogram, invasive blood 
pressure and ear pulse oxymetry were continuously monitored. 
For mechanical ventilation of the sheep and determination of their respiratory parameters, we 
used a Servoventilator 900 connected to a Lung Mechanics Calculator 940 (Siemens AG, 
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Munich, Gennany) 17 . Inspired and expired tidal volumes, inspired and expired minute 
ventilation, respiratory frequency, as well as peak, plateau and end-expiratory pressures were 
directly measured. Computed inspiratory and expiratory resistances and respiratory 
compliance were continuously recorded. 
After a stabilization period of 30 minutes in prone position, a set of control measurements 
including respiratory mechanics, arterial blood gas and hemodynamics were performed. Then 
the endotracheal administration of the Ascaris suum extract aerosol lasting 25 minutes was 
started. A volume of 2.5 ml of Ascaris suum concentrated extract (Greer Laboratories Inc., 
Lenoir, NC, USA) was diluted with physiologie sodium chloride to obtain an aerosol solution 
of 5 ml with a concentration of 18000 protein nitrogen units (PNU) per ml. The aerosol was 
generated using a Pneumatic Drug Nebulizer (Dragerwerk, Lübeck, Germany) which was 
connected to the endotracheal tube and synchronized with the beginning of the inspiratory 
cycle of the ventilator. This system has been demonstrated to provide an aerosol with 80% of 
the dry Ascaris suum extract delivered in the range between O. 1 and 1 µm droplets diameter, 
the mean value being 0,5 µm 18 . To avoid contaminations, a fil ter was placed between the 
nebulizer system and the Y-piece of the circuit. 
During this period and the following 60 minutes, all parameters previously described were 
continuously monitored and recorded every 20 minutes. One hour after the end of the 
sensitization, anesthesia was stopped and the sheep were awakened. A bronchodilator aerosol 
of salbutamol (Ventolin®) 5 mg was systematically administered before extubation. 
All data were expressed as means ± standard deviation (SD). A two-ways ANOVA for 
repeated measurements on one way (tüne) was performed to assess differences between the 
two sessions. A Dunnett's test was performed to detect significant differences between post-
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challenge measurements and baseline values. Differences were considered significant at P 
value< 0.05. Repeatability_was tested according to the method ofBland & Altman19 . 
3, Results 
All animals tolerated the procedure well during the 2 sessions and demonstrated typical 
responses of early bronchoconstriction after Ascaris suum airway challenge. 
During the first session, we observed a significant increase (p<0.05) in peak pressure (31 ± 11 
vs 14 ± 3 cmH20), plateau pressure (26 ± 10 vs 10 ± 3 cmH20), expiratory resistances (26 ± 
6 vs 13 ± 2 cmH20/L/s) and PaC02 (5.5 ± 1.1 vs 4.5 ± 0.3 kPa) along with a significant 
decrease (p<0.05) in respiratory compliance (26 ± 10 vs 45 ± 10 ml/cmH20) and Pa02 (16 ± 
9 vs 32 ± 5 kPa) at the end of the Ascaris suum aerosol (TO + 25') in comparison with 
baseline values (Table 1 and Fig 1). All these changes were maximal at the end of the 
challenge. During the following sixty minutes period, they remained stable and different 
(p<0.05) from control values. 
During the second session, the response to Ascaris suum challenge was similar to the first 
session but less pronounced. Peak pressure ( 31±12 vs 15 ± 4 cmH20), plateau pressure (26 
± 12 vs 11 ± 3 cmH20), expiratory resistances (24 ± 6 vs 13 ± 3 cmH20/L/s), respiratory 
compliance (29 ± 12 vs 48 ± 11 ml/cmH20), Pa02 (17 ± 7 vs 33 ± 9 kPa) and PaC02 (5.7 ± 
2.1 vs 4.5 ± 0.5 kPa) changes were indeed significant at the end of the challenge and also 
remained stable during the next sixty minutes period (Table 2 and Fig 2). 
For the two sessions, cardiovascular parameters were not altered by the Ascaris suum 
challenge. Repeatability coefficients were 13 cmH20 for peak pressure, 12 cmH20 for 
plateau pressure, 15 cmH20/L/ s for expira tory resistance, 17 ml/cmH20 for respira tory 
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compliance, 15 kPa for Pa02 and 2.2 kPa for PaC02. The two-ways ANOV A demonstrated 
no change for peak and plateau pressure, Pa02 and PaC02, whereas expiratory resistances 
and respiratory compliance were significantly different between the two sessions (p<0.05). 
4. Discussion 
This experimental model of early bronchoconstriction offers significant advantages in 
comparison with the traditional animal models of asthma. First, the animal is not stressed 
during the bronchoconstrictive challenge. Secondly, since the resistance is measured via a 
calibrated electronic flowmeter and a pressure transducer incorporated within the ventilator, 
this model does not require a body plethysmograph and thereby simplifies the procedure. This 
animal model offers the possibility to challenge at least twice the same animals after a 
recovery period. Despite a less pronounced bronchoconstrictive response during the second 
session in comparison with the first one, that response is still appropriate because changes 
remain significantly different from control values and stable throughout the study period. It 
should be mentioned however that some animals were initially insensitive to Ascaris suum 
antigen and required several challenges before o btaining an early bronchoconstrictive 
response. 
Our model differs from the one described by Long et al. 16 regarding the anesthetic technique. 
To obtain good hemodynamic stability during and after the bronchoconstrictive challenge, we 
have choosen isoflurane for the maintenance of anesthesia. Pentobarbital administered by 
repetitive intravenous bolus cannot provide stability of heart rate and arterial pressure 16,20 . In 
contrast, our modified model allows to test specifically respiratory effects of new 
bronchodilatory compounds without interference with hemodynamic parameters. 
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From an ethical point of view, the use of general anesthesia offers advantages. The stress 
response induced by the conscious tracheal intubation and the bronchoconstrictive challenge 
with consecutive dyspnea, hypercapnia and hypoxemia 1s blunted21 . Moreover, 
instrumentation of the animals (tracheal intubation, vascular accesses, aerosol administration, 
e.g.) is greatly facilitated. Finally, the use of controlled ventilation and of a pneumatic 
nebulizer permits a synchronized administration of the aerosol with the inspiratory cycle of 
the ventilator and a homogeneous distribution of the aerosol along the entire branchial tree 18 • 
Ideally, the anesthetic should not influence the airway reactivity. Although barbiturates have 
no significant effect on airway reactivity, we did not choose them for maintenance of 
anesthesia due to their rapid accumulation when administrated by continuous intravenous 
infusion22 . The choice of the anesthesia technique was therefore restricted to either 
intravenous administration of propofol or inhalational agents. All these drugs are known to 
have direct and neurally-mediated bronchodilating properties23 -25 . However, at steady state 
this effect is constant and obviously allows to study bronchoconstriction due to Ascaris suum 
exposure. In addition, the observed bronchoconstriction was at least as severe as in awake 
animals 10' 12, indicating again that the isoflurane-induced bronchodilation was relatively mild 
and thus not basically interfering with the antigen-induced bronchoconstriction. 
In conclusion, our simplified experimental model of antigen-induced early 
bronchoconstriction in sheep under general anesthesia with controlled ventilation offers 
several advantages. In comparison with other models, animal welfare is improved, the stress 
response is blunted and the hemodynamic stability is maintained. Our model also allows an 
optimal distribution of the antigen by synchronized pneumatic nebulization and finally avoids 
the need of a body plethysmograph. 
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Figure 1. Time course of peak and plateau pressures, expiratory resistance, respiratory 
compliance, Pa02 and PaC02 after Ascaris suum 1 st session airway challenge. *Significantly 
different from baseline values. 
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Figure 2. Time course of peak and plateau pressures, expiratory resistance, respiratory 
compliance, Pa02 and PaC02 after Ascaris suum 211d session airway challenge. *Significantly 
different from baseline values. 
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Table 1. Physiological parameters before and after Ascaris suum 151 session airway challenge 
Base line End challenge 20 min 40 min 60 min 
(TO) (TO + 25 min) (TO + 45 min) (TO + 65 min) (TO + 85 min) 
Peak pressure, 14 ± 3 31±11 28±10 26 ± 6 24± 4 
cmH20 
Plateau pressure, 10 ± 3 26±10 23 ± 8 21±5 19 ± 3 
cmH20 
Expira tory 13 ± 2 26 ± 6 27 ± 9 28 ± 8 28 ± 8 
resistance, 
cmH20/L/s 
Respira tory 45 ± 10 26± 10 26±10 25 ± 6 26 ± 5 
compliance, 
ml/cmH20 
Pa02, kPa 32 ± 5 16 ± 9 16 ± 9 19 ± 7 21±7 
PaC02, kPa 4.5 ± 0.3 5.5 ± 1.1 5.5 ± 1.1 5.6 ± 1.1 5.7 ± 1.1 
pH 7.51±0.06 7.47±0.10 7.47 ± 0.09 7.45 ± 0.08 7.46 ± 0.08 
Inspira tory tidal 618 ± 82 627 ± 80 627 ± 80 628 ± 80 628 ± 78 
volume, ml 
Heart rate, 85 ± 11 84 ± 14 84 ± 15 86 ± 15 86 ± 15 beats/min 
Mean arterial 80 ± 9 84 ± 24 83 ± 20 81±21 82 ±22 pressure, mmHg 
Temperature, °C 38.5 ± 0.9 38.8 ± 0.8 38.8 ± 0.8 38.9 ± 0.9 38.9 ± 1.0 
Values are means +/- standard deviations (SD). Bold-faced values are significantly different 
from baseline values (p<0.05). 
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Table 2. Physiological parameters before and after Ascaris suum 2n<1 session airway challenge 
Base linc End challenge 20 min 40 min 60 min 
(TO) (TO + 25 min) (TO +45 min) (TO + 65 min) (TO + 85 min) 
Peak pressure, 15 ± 4 31±12 26±10 25 ± 8 25 ± 8 
cmH20 
Plateau pressure, 11±3 26±12 21±9 20 ± 7 19 ± 6 
cmH20 
Expira tory 13 ± 3 24 ± 6 22 ± 7 21±4 22 ± 5 
rcsistancc, 
cmH20/L/s 
Respira tory 48 ± 11 29±12 29±10 30±10 30±11 
compliancc, 
ml/cmH20 
Pa02, kPa 33 ± 9 17 ± 7 17± 6 19 ± 8 22 ± 7 
PaC02, kPa 4.5 ± 0.5 5.7 ±2.1 5.8 ±2.1 5.8 ± 1.8 5.4 ± 1.4 
pH 7.52 ± 0.06 7.47 ± 0.13 7.47 ± 0.13 7.47 ± 0.13 7.48 ± 0.12 
Inspira tory tidal 677 ± 63 669 ± 73 679 ± 63 677 ± 62 677 ± 61 
volume, ml 
Hcart rate, 83 ± 11 90 ± 21 90±19 87 ± 18 85 ± 11 beats/min 
Mean arterial 84 ± 16 95 ±24 92 ± 23 93 ± 22 92 ±21 pressure, mmHg 
Tcmpcrature, °C 38.6 ± 0.5 38.8 ± 0.6 38.8 ± 0.6 38.9 ± 0.6 38.9 ± 0.6 
Values are means +/- standard deviations (SD). Bold-faced values are significantly different 
from baseline values (p<0.05). 
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